Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Arthritis, Rheumatoid D001172 3 associated lipids
Liver Diseases D008107 31 associated lipids
Occupational Diseases D009784 42 associated lipids
Kidney Diseases D007674 29 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Myocardial Infarction D009203 21 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Hyperplasia D006965 34 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Myocardial Ischemia D017202 11 associated lipids
Alcoholism D000437 27 associated lipids
Hypocalcemia D006996 12 associated lipids
Brain Ischemia D002545 89 associated lipids
Epilepsy D004827 35 associated lipids
Testicular Neoplasms D013736 5 associated lipids
Myocardial Reperfusion Injury D015428 20 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Isnardi V et al. Is [(99m)Tc]glucarate uptake mediated by fructose transporter GLUT-5? 2012 Nucl. Med. Biol. pmid:23084044
Moretto A and Lotti M Exposure to toluene increases the urinary excretion of D-glucaric acid. 1990 Br J Ind Med pmid:2310708
Froessler B et al. Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial. 2013 J. Matern. Fetal. Neonatal. Med. pmid:23130909
Labadarios D et al. The effects of chronic drug administration on hepatic enzyme induction and folate metabolism. 1978 Br J Clin Pharmacol pmid:23138
Bhattacharya S et al. The prophylactic role of D-saccharic acid-1,4-lactone against hyperglycemia-induced hepatic apoptosis via inhibition of both extrinsic and intrinsic pathways in diabetic rats. 2013 Food Funct pmid:23138840
pmid:23166216
Devasenapathy N et al. Is intravenous iron sucrose the treatment of choice for pregnant anemic women? 2013 J. Obstet. Gynaecol. Res. pmid:23167561
Goldstein SL et al. Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: a randomized controlled trial. 2013 Am. J. Kidney Dis. pmid:23245582
Blanco Rubio N et al. [Preoperative intravenous iron as a strategy for blood saving in surgery for hip fracture]. 2013 Med Clin (Barc) pmid:23246172
Lee ES et al. Comparison of adverse event profile of intravenous iron sucrose and iron sucrose similar in postpartum and gynecologic operative patients. 2013 Curr Med Res Opin pmid:23252876
Bhattacharya S et al. D-saccharic acid 1,4-lactone protects diabetic rat kidney by ameliorating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via NF-κB and PKC signaling. 2013 Toxicol. Appl. Pharmacol. pmid:23261973
Moorani KN and Asim S Parenteral iron sucrose in iron deficiency anaemia of paediatric chronic kidney disease. 2011 Jul-Sep J Ayub Med Coll Abbottabad pmid:23272434
pmid:23316876
Moore KL et al. Uncommon adverse effect of a common medication. 2013 Tidsskr. Nor. Laegeforen. pmid:23344600
Araki T et al. Clinical efficacy of two forms of intravenous iron--saccharated ferric oxide and cideferron--for iron deficiency anemia. 2012 Pharmazie pmid:23346769
Newman MA et al. Biological monitoring screening of patients provided antineoplastic drugs including adriamycin, cyclophosphamide, 5-fluorouracil, methotrexate, and vincristine. 1990 Cancer Res. pmid:2334930
pmid:23364652
Basora M et al. Optimizing preoperative haemoglobin with intravenous iron. 2013 Br J Anaesth pmid:23404979
Dwivedi C et al. Effect of calcium glucarate on beta-glucuronidase activity and glucarate content of certain vegetables and fruits. 1990 Biochem. Med. Metab. Biol. pmid:2346674
Yamamoto S et al. Iatrogenic osteomalacia: report of two cases. 2013 J. UOEH pmid:23475021
Yang Z et al. Parasitic nematode-induced modulation of body weight and associated metabolic dysfunction in mouse models of obesity. 2013 Infect. Immun. pmid:23509143
Mishra A et al. Fatal anaphylactic reaction to iron sucrose in pregnancy. 2013 Jan-Feb Indian J Pharmacol pmid:23543624
Douard V et al. Excessive fructose intake causes 1,25-(OH)(2)D(3)-dependent inhibition of intestinal and renal calcium transport in growing rats. 2013 Am. J. Physiol. Endocrinol. Metab. pmid:23571713
Ho YD and Ho KJ Biliary D-glucaric acid: its quantitation and preventive role in gallstone formation. 1990 Scand. J. Gastroenterol. pmid:2359994
Munoz C et al. Klotho sensitivity of the hERG channel. 2013 FEBS Lett. pmid:23603386
Bespalov VG and Aleksandrov VA [Anticarcinogenic effect of potassium salts of glucaric and glucuronic acid in induced models of cervical and esophageal tumors]. 2012 Vopr Onkol pmid:23607211
Lynn S and McDaniel J Managing severe anemia when the patient is a Jehovah's Witness. 2013 JAAPA pmid:23610833
Elford P et al. Biodistribution and predictive hepatic gene expression of intravenous iron sucrose. 2013 Nov-Dec J Pharmacol Toxicol Methods pmid:23624021
Biggar P and Hahn KM [Importance of the different i.v. iron generations for everyday medical practice]. 2013 MMW Fortschr Med pmid:23678667
Beck-da-Silva L et al. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. 2013 Int. J. Cardiol. pmid:23680589
pmid:23681275
Barot BS et al. Physicochemical and structural characterization of iron-sucrose formulations: a comparative study. 2014 Pharm Dev Technol pmid:23701359
Janus N et al. Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC survey. 2013 Support Care Cancer pmid:23715817
Wang Y et al. Hepatoprotective effects of kombucha tea: identification of functional strains and quantification of functional components. 2014 J. Sci. Food Agric. pmid:23716136
Potthoff SA and Münch HG [Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease]. 2013 Dtsch. Med. Wochenschr. pmid:23737117
García Erce JA et al. [Thoughts about the usefulness of the preoperatory administration of intravenous iron in hip fracture surgery]. 2013 Med Clin (Barc) pmid:23790583
Kowalczyk MC et al. Effects of combined phytochemicals on skin tumorigenesis in SENCAR mice. 2013 Int. J. Oncol. pmid:23835587
Galanopoulou P et al. Effect of enzyme induction on bioavailability of hetacillin in patients treated with anticonvulsants and chlorpromazine. 1990 Jan-Mar Eur J Drug Metab Pharmacokinet pmid:2384113
Beguin Y et al. Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial. 2013 Am. J. Hematol. pmid:23873823
pmid:23890881
Contreras C et al. Comparative study of the oral absorption of microencapsulated ferric saccharate and ferrous sulfate in humans. 2014 Eur J Nutr pmid:23892521
pmid:23895304
Tian B et al. Predicting enzyme-substrate specificity with QM/MM methods: a case study of the stereospecificity of (D)-glucarate dehydratase. 2013 Biochemistry pmid:23901785
Giger M and Achermann R [Iron substitution in outpatients in Switzerland: Increase of costs associated with intravenous administration]. 2013 Z Evid Fortbild Qual Gesundhwes pmid:23916272
Latham AN Effect of in vitro changes in urinary pH on the enzymatic measurement and daily variation in excretion of D-glucaric acid. 1975 J. Pharm. Pharmacol. pmid:239180
Beck-da-Silva L et al. Iron therapy in patients with heart failure. A straight shot. 2013 Int. J. Cardiol. pmid:23931974
Roots I et al. Comparison of methods to study enzyme induction in man. 1975 Adv. Exp. Med. Biol. pmid:239546
Onken JE et al. Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. 2014 Nephrol. Dial. Transplant. pmid:23963731
Grim K et al. Treatment of childhood-onset restless legs syndrome and periodic limb movement disorder using intravenous iron sucrose. 2013 Sleep Med. pmid:23993871
Vadasz D et al. Intravenous iron sucrose for restless legs syndrome in pregnant women with low serum ferritin. 2013 Sleep Med. pmid:24012019